White label ELPA - ClinicalTrials.eu

Long-Term Safety Study of ST-920 Gene Therapy for Patients with Fabry Disease

Not recruiting

2 1 1
Investigated Drugs:
- Isaralgagene Civaparvovec
Study on the Effects and Safety of Ginkgo Biloba Extract in Patients with Cognitive Impairment After COVID-19

Not recruiting

2 1 1
Study on the Safety and Effectiveness of Sirolimus for Treating Drug-Resistant Epilepsy in Children with Rare Brain Disorders Linked to mTOR Pathway Activation

Not recruiting

2 1 1 1
Investigated Diseases:
- Cortical dysplasia
- Epilepsy
Investigated Drugs:
- Sirolimus
Study on How Nitrous Oxide and Oxygen Affect Lung Health in Children with Respiratory Disorders

Not recruiting

2 1 1 1
Investigated Diseases:
- Respiratory distress
Investigated Drugs:
- Nitrous Oxide
- Oxygen
Study of Avelumab and Axitinib for Patients with Unresectable or Metastatic Gastrointestinal Stromal Tumors After Standard Therapy Failure

Not recruiting

2 1 1 1
Investigated Diseases:
- Gastrointestinal stromal tumour
Investigated Drugs:
- Avelumab
- Axitinib
Study of S227928 Alone and with Venetoclax for Patients with Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Not recruiting

2 1 1 1
Investigated Drugs:
Study of SAR441566 compared to placebo for adults with moderate to severe Crohn’s disease

Not recruiting

2 1
Investigated Diseases:
- Crohn’s disease
+5
Study of GDC-8264 compared to placebo for preventing kidney injury in patients at risk of acute kidney injury after heart surgery

Not recruiting

2 1
Investigated Diseases:
- Acute kidney injury
Investigated Drugs:
- RO7288817
Study on NTLA-2002 for Treating Hereditary Angioedema in Patients: Evaluating the Effects of Ziclumeran and Lonvoguran

Not recruiting

3 1 1
Investigated Drugs:
Study on the Effectiveness and Safety of Sonrotoclax and Zanubrutinib for Adults with Untreated Chronic Lymphocytic Leukemia

Not recruiting

2 1 1 1
Investigated Diseases:
- Chronic lymphocytic leukaemia
Investigated Drugs:
- N-[4-({[(1R,4R)-4-Hydroxy-4-Methylcyclohexyl]Methyl}Amino)-3- Nitrobenzene-1-Sulfonyl]-4-(2-{(2S)-2-[2-(Propan-2-Yl)Phenyl]Pyrrolidin1-Yl}-7-Azaspiro[3.5]Nonan-7-Yl)-2-[(1H-Pyrrolo[2,3-B]Pyridin-5- Yl)Oxy]Benzamide
- Zanubrutinib

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies